Ramonville Saint Agne, France

Isabelle Lattes

This inventor holds 1 USPTO granted patent. Top assignee: Chauvin Opsia. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Isabelle Lattes

Introduction

Isabelle Lattes is a prominent inventor based in Ramonville Saint Agne, France. She has made significant contributions to the field of ophthalmology through her innovative work on fluorinated organic compounds. Her dedication to research and development has led to the creation of valuable patents that enhance medical applications.

Latest Patents

Isabelle holds a patent for "Fluorinated organic compounds, ophthalmological applications thereof." This patent showcases her expertise in developing compounds that can potentially improve treatments in the field of eye care. With 1 patent to her name, she continues to push the boundaries of innovation.

Career Highlights

Throughout her career, Isabelle has been associated with Chauvin Opsia, a company known for its commitment to advancing ophthalmological solutions. Her role at the company has allowed her to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Isabelle has worked alongside notable colleagues, including Brigitte Guidetti and Viviane Payrou. Their combined efforts have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Isabelle Lattes exemplifies the spirit of innovation in the field of ophthalmology. Her work on fluorinated organic compounds not only highlights her expertise but also her commitment to improving medical treatments. Through her career and collaborations, she continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…